NJ Court Nixes Trade Secrets Row Over Generic Cough Syrup
Law360, New York (August 27, 2013, 3:56 PM EDT) -- A New Jersey appeals court on Tuesday rejected UCB Manufacturing Inc.’s breach of contract and unfair competition claims in its suit accusing a former employee of disclosing confidential information to rival Tris Pharma Inc. to develop a generic version of UCB’s previously patented Tussionex cough medicine.
A three-judge panel of the New Jersey Superior Court’s Appellate Division affirmed a lower court’s 2011 decision granting summary judgment to defendants Tris Pharma and Yu-Hsing Tu, a scientist and drug formulator who worked with UCB’s predecessors from 1990 to 2001 but later joined Tris Pharma as vice president of research and development.
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!